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The pathogenesis of testicular germ cell tumours (GCTs) is potentially influenced by high-energy nutrition during infancy. As adult
height is a proxy for childhood nutrition, we investigated the role of nutrition in GCT pathogenesis by comparing stature of patients
with healthy men. In a matched case–control study, 6415 patients with GCT were compared with healthy army conscripts
(1:6 matching modus) with regard to height (cm) and body mass index (BMI; kg/m
2). Statistical analysis involved tabulation of
descriptive height measures and BMI. Conditional logistic regression models were used to quantify the association of GCT with
height, with odds ratios (OR) adjusted for BMI. The literature was searched for studies on stature in GCT patients. Body size is
significantly associated with risk of GCT, very tall men (4195cm) having a GCT risk of OR¼3.35 (95% confidence intervals (CI):
2.88–3.90; adjusted). Short stature is protective (OR¼0.798; 95% CI: 0.68–0.93). Both histologic subgroups are associated with
tallness. Of 16 previous reports, 7 were confirmative, 5 had null and 4 equivocal results. The association of stature with GCT risk
accords with the nutrition hypothesis of GCT. This study expands the current view of GCT tumorigenesis by suggesting that
high-calorie intake in childhood promotes GCT precursors originating in utero.
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Adult stature results from a combination of genetic and
environmental factors (Sinclair and Dangerfield, 1998). The most
important environmental element impacting on childhood growth
is nutrition (Gunnell et al, 2001). Attained adult height can thus
be used as a biomarker for early childhood energy intake
(Albanes et al, 1988). There is some indication for a positive
association between adult height and overall risk of malignancy
(Batty et al, 2006), although the data reported are inconsistent as
yet (Giovannucci et al, 2004).
Testicular germ cell tumours (GCTs) are thought to originate
in utero. Precursors of GCT, closely resembling primordial
germ cells evolve in the primitive gonad, secondary to excess
maternal oestrogen levels during embryogenesis (Dieckmann and
Skakkebaek, 1999; Hoei-Hansen et al, 2005). Putatively, these
precursors of malignancy may be promoted by factors acting
during early childhood (Dieckmann and Pichlmeier, 2004), such as
high-calorie nutrition. This assumption is mostly based on the
observation that GCT incidence significantly decreased in post-war
periods in Europe, when nutrition was mainly poor (Moller, 1993;
Bray et al, 2006). Although, an association of GCT with tallness has
often been postulated (Ehrengut et al, 1980), there are in-
consistencies among the studies. In particular, methodological
design was vastly different among the studies and some of the
analyses were hampered by small sample size (Kleinteich and
Marx, 1983; Whittemore et al, 1984). We have therefore,
investigated the presumed association of GCT with height in a
large patient sample and summarised previous data relating to this
issue in the hope of resolving the question of tallness and GCT.
MATERIALS AND METHODS
This investigation was designed as a matched case–control study
with 228 participating institutions (appendix). Accrual started in
2002 and was terminated by the end of 2005. Cases treated during
1995–2005 were eligible (Dieckmann, 2007). Roughly 60% of
the cases were enroled retrospectively. A total of 6415 patients
were registered from all regions across Germany, ages ranging
from 18 to 40 years. All were of Caucasian descent, and all
had histologically confirmed testicular GCT, 58.4% non-seminoma
and 41.6 % pure seminoma. Army conscripts of the German Army
(Deutsche Bundeswehr) served as healthy controls. Data on
national cohorts of conscripts born between 1965 and 1984 were
supplied electronically by the Army Institute of Medical Statistics
(Institut fu ¨r Wehrmedizinalstatistik, Andernach), comprising
4357977 entries with anthropometric data of entire cohorts of
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yyoung men aged 18–19 years examined by the German Army
nation-wide during enrolment years 1985–2005.
The following anthropometric measures were recorded for each
patient and control, respectively: Height (cm), weight (kg), and
body mass index (BMI; kg/m
2), as well as the exact date of birth.
Histology of GCT was noted (pure seminoma or non-seminoma).
Measurements for controls were those taken at military enrolment,
whereas those for patients were mainly self-reported. As final adult
height is usually attained at the age of 18–19 years, comparison of
army conscripts with adult GCT patients is reasonable with respect
to height. However, as body weight and BMI mostly continue to
increase beyond age 19 (Mensink et al, 2005), these young army
conscripts are no appropriate controls to compare with adult GCT
patients. Accordingly, this analysis is limited to the role of adult
height. Yet, data on BMI were recorded for purposes of adjustment
in the course of statistical analysis.
For statistical comparison, a matching of patients with control
persons according to exact date of birth was designed. In light of
the minor variations regarding mean adult height among eastern
and western regions in Germany, (Jaeger et al, 2001) we elected to
employ a set of six individually matched control persons for each
patient to overcome the potential confounding caused by regional
variation. The final control population thus consisted of n¼38490
participants. In cases where more than six subjects were available
for control among the original database, a random selection was
performed.
Statistical analysis
Matching and statistical analysis was accomplished by employing
SAS software package (V.9. 1.3) on the Windows platform. First, a
descriptive tabulation was performed regarding median height,
25th percentiles, 75th percentiles, as well as maximum and
minimum height as found in the populations of GCT patients,
controls, and in the subsets of seminoma and non-seminoma,
respectively. For further detailed analysis, patients and controls
were categorised with respect to height and BMI, respectively.
Categories were o170, 170–174, 175–179, 180–184, 185–189,
190–194, X195 with regard to height (cm), and o20, 20 to o25,
25 to o30, X30 with respect to BMI (kg/m
2). As the median height
of German males aged 18–40 years currently ranges from 176
to 179cm, the height category 175–179cm was defined as the
reference group. Conditional logistic regression models (Armitage
et al, 2001) were calculated to obtain odds ratios (OR) and 95%
confidence intervals (CIs) with and without adjustment for the
potentially confounding factor, BMI. The Wald w
2-test was used
to test the overall significance of each model parameter.
To identify previous controlled studies of adult height and
testicular GCT, a literature survey was performed using electronic
search systems (PubMed) and hand search of pertinent literature.
RESULTS
Analysis revealed that all statistical parameters of height that is,
median, minimum, maximum, 25th percentile and 75th percentile
are greater in patients than in controls (Table 1), whereas the
subgroups of seminoma and non-seminoma, showed similar
results (Table 1). With respect to height categories, the group
‘180–184cm’ is the most frequent in both patients and controls,
but those with taller height (i.e. 4185cm) are distinctly more
frequent among cases than in controls, as with the subgroups of
seminoma and non-seminoma. Conditional regression modelling
with body height as the only parameter, given in Table 2, showed
overall significant difference in relative frequencies of height
categories between cases and controls (Po0.0001; Wald w
2-test).
There is a significantly increasing risk of GCT with increasing
height. As height may conceivably be interrelated with other
anthropometric parameters, a descriptive analysis was performed
stratifying by BMI categories. As shown in Table 3, patients exceed
controls with respect to height in all of the BMI categories
indicating that its confounding effect on GCT risk can only be low.
Conditional logistic regression adjusting for BMI confirmed the
significant association of height with the risk of GCT (Table 2) and
point estimates were almost equal in crude and adjusted models. It
can be noted that shorter than average individuals (o170cm) were
at significantly decreased risk (OR¼0.798; 95% CI: 0.688–0.926).
Beyond average height, there is an incremental gain in risk with
increasing categories of height. Very tall subjects (4195cm) have
a markedly increased risk (OR¼3.35; 95% CI: 2.88–3.903).
Homogeneous results were obtained after stratification into
histological subtypes of GCT (Table 2). The findings were even
more distinct when the lowest height category (o170cm) was set
as a reference in the logistic regression model. Then the highest
category (4195cm) showed an OR¼4.199 (95% CI: 3.452–5.109)
for GCT overall, and OR¼4.045, and OR¼4.345 for seminoma
and non-seminoma, respectively. Sixteen previous reports on
GCT in relation to height were identified, involving a total of
6602 cases.
DISCUSSION
Our study revealed a strongly significant association of adult
height with the risk of testicular GCT. It is unique in three ways:
first, it is by far the largest study to date; second, it included the
highest risk ever reported; finally, there is a linear trend with
increments of height whereas a distinctly decreased risk is found
with short stature. The overall relative risk (OR) is 3.35 whereas
previous OR ranged from 1.83 to 2.11 (Dieckmann and Pichlmeier,
2002; Swerdlow et al, 1989; McGlynn et al, 2007). It can be noted
that GCT patients exceeded controls with respect to all the
statistical measures of height, with both histological subgroups of
GCT showing similar associations.
The results of the present evaluation are in line with seven
previous studies (Kleinteich and Marx, 1983; Gallagher et al, 1995;
Dieckmann and Pichlmeier, 2002; Rasmussen et al, 2003; Richiardi
et al, 2003; Hardell et al, 2006; McGlynn et al, 2007) encompassing
3098 patients. Nine other studies had failed to demonstrate a
significant correlation of body size with GCT risk (Whittemore
et al, 1984; Swerdlow et al, 1989; Thune and Lund, 1994; UK
Testicular Cancer Study Group, 1994; Davies et al, 1990, 1996;
Petridou et al, 1997; Bjørge et al, 2006; Stang et al, 2006). However,
it should be noted that three of these investigations found OR
of borderline to be nonsignificant (Swerdlow et al, 1989; UK
Testicular Cancer Study Group, 1994; Stang et al, 2006), and two
disclosed significant associations with only one histological group
of GCT (Bjørge et al, 2006; Stang et al, 2006). Importantly, there
was no antithethical result. A formal meta-analysis of the above-
mentioned studies is unfeasible because of the great differences in
Table 1 Descriptive statistical analysis of height measures (cm)
n Min. 25th pctl Median 75th pctl Max.
GCT 6415 150 177 181 186 211
Controls 38490 145 175 180 184 210
Seminoma 2667 150 177 182 186 207
Controls 16002 145 175 180 184 210
Non-seminoma 3748 150 177 181 186 211
Controls 22488 145 175 180 184 208
GCT¼germ cell tumour; min.¼minimum height; max.¼maximum height;
pctl¼percentile.
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categories. Overall, the huge present database in conjunction with
the previous studies listed here provides compelling evidence for
a virtually existing association of adult height with the risk of GCT.
This study has a number of strengths. The exceptional sample
size leaves statistical chance effects at a minimum. Selection bias
is unlikely because accrual of patients was performed nation-wide
by 228 participating institutions across Germany. Similarly,
the control population represented national standard because
basically all young German men are enroled by the Federal Army.
Confounding by age is ruled out because cases and controls were
exactly matched by the day of birth. Conditional logistic regression
models were with and without adjusting for BMI. As BMI is
mainly associated with energy intake during adulthood, confound-
ing of the present result by nutritional effects after adolescence
is improbable. Yet, the study has certain weaknesses, such as
controlling only for age and BMI. Anthropometric measures of
patients were self-reported for the most part, whereas all of the
controls had exactly measured values. As many men overestimate
their own height (Blumer, 2007) there may be a systematic bias in
the present results, but this is probably only modest. Over-
estimation of height usually does not exceed 1–2cm, and mostly
only men of short stature will do so. In this study, the proportions
of categories with very tall men are distinctly higher among cases
than controls, and too great for overestimation bias alone to
explain. Moreover, there is some suggestion that overestimation of
height is lower in patients than in healthy individuals (McGlynn
et al, 2007). Individuals examined during military enrolment at
age 18 could have developed GCT in later life. In that event, these
individuals would represent grossly inappropriate controls. As,
the life-time risk of a German male developing GCT is less than
1% (Dieckmann and Pichlmeier, 2004), the proportion of controls
who might later become affected is far too low to represent a bias.
The association of tallness with testicular cancer risk lends
much support to the nutrition hypothesis of GCT pathogenesis. In
general, that theory implies an association of nutrition with
GCT risk (McGlynn, 2001). As final adult height is largely
determined during the first 2 years of life, it may be postulated
from the present data that high-calorie nutrition after birth could
have promoting or at least conserving effects on GCT precursor
cells that are known to evolve during the intra-uterine period
(Dieckmann and Pichlmeier, 2004). Direct evidence to support this
hypothesis is difficult to establish. However, there are numerous
indirect observations in accordance with the theory.
The main observation is the declining incidence rates of GCT
in cohorts of men born during World War II or immediately
thereafter (Moller, 1993; Bray et al, 2006). In that period
malnutrition was common in Europe. When food supply improved
some years later incidence rates resumed. The secular trend of
increasing adult stature over time has been observed in many
countries for many years. Similarly, the incidence rates of GCT
have been increasing ever since (Garner et al, 2005; Bray et al,
Table 3 Quantitative distribution of body height stratified by BMI category
BMI (kg/m
2) Pop. n Min. (cm) 25th pctl (cm) Median (cm) 75th pctl (cm) Max. (cm)
o 20 Controls 7880 157 176 180 185 210
Cases 436 155 177 182 187 202
20 to o25 Controls 23812 148 175 180 184 210
Cases 3300 150 177 181 186 211
25 to o30 Controls 5327 156 175 180 184 208
Cases 2062 150 177 181 186 204
30+ Controls 1471 145 175 179 184 203
Cases 617 154 176 180 186 206
BMI¼body mass index; max.¼maximum; min.¼minimum; pctl¼percentile; pop.¼population.
Table 2 Conditional logistic regression with body height as covariate – unadjusted and adjusted for BMI, stratified for all GCT cases, seminoma, and
non-seminoma cases
All GCT cases Seminoma cases only Non-seminoma cases only
Unadjusted for BMI Adjusted Unadjusted Adjusted Unadjusted Adjusted
Height (cm)
a OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
o170 0.815 0.705–0.941 0.798 0.688–0.926 0.882 0.707–1.100 0.842 0.668–1.059 0.769 0.635–0.931 0.764 0.629–0.929
170–174 0.955 0.868–1.050 0.928 0.841–1.023 0.943 0.811–1.095 0.895 0.766–1.047 0.963 0.852–1.089 0.946 0.834–1.072
175–179 1.0 1.0 1.0 1.0 1.0 1.0
180–184 1.408 1.306–1.519 1.387 1.283–1.499 1.417 1.260–1.593 1.395 1.235–1.576 1.403 1.271–1.548 1.380 1.248–1.526
185–189 1.542 1.419–1.676 1.575 1.445–1.717 1.597 1.403–1.817 1.641 1.433–1.878 1.505 1.349–1.678 1.531 1.369–1.712
190–194 1.979 1.781–2.199 2.069 1.854–2.309 2.094 1.776–2.469 2.232 1.876–2.656 1.903 1.658–2.184 1.970 1.710–2.270
X195 3.194 2.764–3.691 3.353 2.880–3.903 3.201 2.570–3.987 3.404 2.691–4.306 3.192 2.634–3.868 3.322 2.720–4.056
CI¼confidence interval; GCT¼germ cell tumour; OR¼odds ratio.
aThe overall effect of body height is statistically significant in both models, unadjusted and adjusted for BMI
(Wald w
2-test Po0.0001).
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are interrelated or just co-existent is unknown because the
underlying reasons for both of these developments are obscure.
However, what may point to a biological association is the fact that
both of the developments could at least partly be explained by the
increasing availability of food in the high-incidence nations over
time. What also may suggest a true association is the observation
that both trends, increasing GCT incidence rates (Pharris-Ciurej
et al, 1999) and increasing adult stature (Jaeger et al, 2001), have
potentially begun to abate.
Some decades ago, GCT had been found to be more frequent in
‘white-collar professions’ (Mustacchi and Millmore, 1976). That
observation could also fit with the nutrition hypothesis because
usually, white-collar professionals belonged to economically
privileged classes and food supply was obviously sufficient.
Currently, food deficiency is no longer a general problem in
Western countries. Conversely, there is a clear trend towards
higher prevalence of overweight and obesity, which is predomi-
nantly true in lower social classes. Accordingly, social gradients
regarding GCT prevalence have levelled off (Pukkala and
Weiderpass, 2002; Dieckmann and Pichlmeier, 2004). Overweight
has also become a growing problem among Black American
citizens (Hedley et al, 2004). In that subpopulation, GCT used to be
a rather rare disease (Mustacchi and Millmore, 1976) and it is of
particular note that the incidence has recently started to rise
markedly (McGlynn et al, 2005).
Two ecological studies support the hypothesis, one showing
a correlation between high-fat intake and the incidence of GCT
(Armstrong and Doll, 1975) and the other reporting an association
of dairy products specifically cheese, with the incidence of
testicular cancer (Ganmaa et al, 2002). It is to be noted that, a
Swedish cohort study reported an increased risk of GCT for
individuals having high cholesterol levels at the edge of adulthood
(Wirehn et al, 2005). As serum cholesterol levels may serve as a
proxy for high-energy intake, it may be speculated that high fat
consumption during childhood may have a bearing on GCT
pathogenesis. Four case–control studies supported the connection
of GCT risk with dairy food consumption (Davies et al, 1996;
Sigurdson et al, 1999; Garner et al, 2003; Stang et al, 2006)
whereas three others did not (Bonner et al, 2002; Walcott et al,
2002; McGlynn et al, 2007). Overall, direct evidence by controlled
studies to support the nutrition hypothesis of GCT is scarce;
however, the bulk of indirect evidence is clearly in favour of
the hypothesis.
There is now sufficient evidence to acknowledge tallness as a
recognised risk factor of testicular GCT. The underlying biological
mechanisms linking tallness and GCT risk are less clear. However,
the nutrition hypothesis outlined herein would provide an
appealing explanation. According to that hypothesis, high-calorie
intake during early childhood could advance length growth and
promote GCT precursor cells at the same time. This hypothesis
would thus complement and refine the current view of GCT
pathogenesis that involves the development of GCT precursor cells
during intra-uterine life.
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